title: Stimulation of mouse Cyp1b1 during adipogenesis: characterization of promoter activation by the transcription factor Pax6.
abstract: Cytochrome P4501B1 (Cyp1b1) is expressed specifically in certain neural crest (NC) cells during embryogenesis. Mesenchymal progenitor cells that develop from NC cells are modeled here by mouse C3H10T1/2 and 3T3-L1 cells. Dexamethasone in combination with methylisobutylxanthine (DM) induces Cyp1b1 and a 6.7 kb mouse Cyp1b1 promoter-luciferase reporter in each cell type prior to adipogenesis. An 18 base sequence (at -6.11 kb) (PaxE) which was essential for this reporter stimulation in 3T3-L1 cells bound the transcription factor Pax6. This is shown by gel mobility shifts and sequence mutations. Heterologous vector expression of Pax6 in 3T3-L1 cells enhanced DM stimulated Cyp1b1 promoter activity through cooperation with two Sp1 sites in the proximal promoter region. Chromatin immunoprecipitation showed that DM stimulated binding of Pax6 adjacent to Sp1 in the proximal promoter more than in the PaxE region. The Cyp1b1 induction by DM in C3H10T1/2 cells was more rapid but independent of Pax6. The far upstream enhancer region (FUER) found in rat Cyp1b1 responded to DM but was inactive in the mouse promoter due to key sequence changes. The expression patterns of Pax6 and Cyp1b1 frequently overlap during mouse embryogenesis. The relationship between Pax6 and Cyp1b1 expression warrants further investigation, particularly in the NC.
authors: Department of Pharmacology, University of Wisconsin, Madison, WI 53706, USA. wxz62@case.edu
authors: Wenchao
authors: W
authors: Zheng
authors: Tiegang
authors: T
authors: Tong
authors: Jinwoo
authors: J
authors: Lee
authors: Xueqing
authors: X
authors: Liu
authors: Craig
authors: C
authors: Marcus
authors: Colin R
authors: CR
authors: Jefcoate
mesh_terms: D041721:3T3-L1 Cells; D050156:Adipogenesis; D000818:Animals; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics* / Q000378:metabolism; D001483:Base Sequence; D002460:Cell Line; D065633:Cytochrome P-450 CYP1B1; D003907:Dexamethasone / Q000378:metabolism*; D004742:Enhancer Elements, Genetic; D005136:Eye Proteins / Q000235:genetics / Q000378:metabolism*; D018507:Gene Expression Regulation, Developmental; D018398:Homeodomain Proteins / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D008969:Molecular Sequence Data; D000071841:PAX6 Transcription Factor; D047495:PPAR gamma / Q000235:genetics; D051761:Paired Box Transcription Factors / Q000235:genetics / Q000378:metabolism*; D011401:Promoter Regions, Genetic; D011485:Protein Binding; D051381:Rats; D012097:Repressor Proteins / Q000235:genetics / Q000378:metabolism*; D014162:Transfection
chemical_list: D005136:Eye Proteins; D018398:Homeodomain Proteins; D000071841:PAX6 Transcription Factor; D047495:PPAR gamma; D051761:Paired Box Transcription Factors; C000605732:Pax6 protein, mouse; C000605733:Pax6 protein, rat; D012097:Repressor Proteins; D003907:Dexamethasone; D001189:Aryl Hydrocarbon Hydroxylases; C585498:Cyp1b1 protein, mouse; C585499:Cyp1b1 protein, rat; D065633:Cytochrome P-450 CYP1B1
references: Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4333-7
references: 9539737
references: Toxicol Appl Pharmacol. 2005 Aug 22;207(1):39-58
references: 16054899
references: Hum Mol Genet. 1997 Apr;6(4):641-7
references: 9097971
references: J Immunol. 2012 Sep 1;189(5):2614-24
references: 22855714
references: Mol Vis. 2004 Aug 30;10:629-36
references: 15359218
references: Mol Pharmacol. 2008 Feb;73(2):509-17
references: 17962386
references: Genes Cells. 2002 Aug;7(8):791-805
references: 12167158
references: Dev Genes Evol. 2000 Dec;210(12):644-50
references: 11151303
references: Nucleic Acids Res. 2001 Mar 1;29(5):1228-37
references: 11222774
references: Mol Pharmacol. 2005 Feb;67(2):499-512
references: 15523052
references: Stem Cells. 2012 Jun;30(6):1152-62
references: 22415977
references: Mol Vis. 2010 Mar 03;16:341-52
references: 20216939
references: Mol Cell Endocrinol. 2002 Sep 30;195(1-2):27-38
references: 12354670
references: J Biol Chem. 1996 Nov 8;271(45):28324-30
references: 8910454
references: Genes Dev. 1994 Sep 1;8(17):2022-34
references: 7958875
references: Drug Metab Dispos. 2005 Apr;33(4):489-94
references: 15616152
references: Neural Dev. 2009 Feb 10;4:6
references: 19208226
references: Development. 2007 Apr;134(7):1369-83
references: 17329364
references: Arch Biochem Biophys. 2003 Aug 1;416(1):53-67
references: 12859982
references: J Cell Biochem. 2004 Feb 1;91(2):336-53
references: 14743393
references: J Orthop Res. 2005 Nov;23(6):1383-9
references: 15936917
references: J Biol Chem. 1994 May 27;269(21):14905-11
references: 8195121
references: Mol Cell Biol. 1995 May;15(5):2858-71
references: 7739566
references: J Biol Chem. 2005 Oct 21;280(42):35228-37
references: 16115881
references: FASEB J. 2012 Apr;26(4):1462-72
references: 22202673
references: Annu Rev Cell Dev Biol. 2009;25:431-56
references: 19575673
references: Biochim Biophys Acta. 2009 May;1789(5):403-12
references: 19217949
references: Toxicol Appl Pharmacol. 2003 Oct 15;192(2):174-90
references: 14550751
references: Development. 1996 Sep;122(9):2639-50
references: 8787739
references: Mol Cell Biol. 1999 Dec;19(12):8272-80
references: 10567552
references: J Cell Sci. 2001 Aug;114(Pt 15):2809-17
references: 11683414
references: Cell. 1974 Oct;3(2):127-33
references: 4426090
references: J Biol Chem. 1994 Mar 18;269(11):8355-61
references: 8132558
references: Mol Cell Biol. 2009 May;29(10):2483-8
references: 19273606
references: J Biol Chem. 2007 May 11;282(19):13954-65
references: 17374606
references: J Clin Invest. 2009 Jan;119(1):110-24
references: 19065047
references: J Cell Sci. 1998 Nov;111 ( Pt 22):3311-22
references: 9788873
references: Science. 2003 Mar 7;299(5612):1578-81
references: 12624268
references: J Pineal Res. 2010 Jan;48(1):55-64
references: 19919601
references: Mol Cell Biol. 1999 Aug;19(8):5495-503
references: 10409739
references: Cell. 1994 Dec 30;79(7):1147-56
references: 8001151
references: Am J Physiol Cell Physiol. 2010 Mar;298(3):C665-78
references: 20032512
references: Toxicol Sci. 2007 Nov;100(1):180-93
references: 17686920
references: Hum Mol Genet. 1997;6(10):1667-77
references: 9300658
references: Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):44-9
references: 12502791
references: Gene. 2012 Oct 15;508(1):1-8
references: 22835698
references: Toxicol Appl Pharmacol. 2005 Feb 1;202(3):215-28
references: 15667827
references: Biochem Pharmacol. 2003 Dec 15;66(12):2313-21
references: 14637189
references: Mol Pharmacol. 2010 Oct;78(4):608-16
references: 20631054
references: Cell. 1995 Dec 1;83(5):803-12
references: 8521497
references: PLoS One. 2009;4(1):e4159
references: 19132093
references: J Biol Chem. 1999 May 21;274(21):15115-26
references: 10329718
references: J Neurochem. 2007 Oct;103(2):650-65
references: 17666047
references: J Biol Chem. 1995 May 12;270(19):11595-602
references: 7744798
references: Mol Cell Endocrinol. 2011 Jan 30;332(1-2):116-24
references: 20937355
references: Mol Pharmacol. 2008 Dec;74(6):1649-56
references: 18779363
references: Annu Rev Pharmacol Toxicol. 2001;41:297-316
references: 11264459
references: Drug Metab Dispos. 2000 Mar;28(3):315-22
references: 10681376
references: J Biol Chem. 1998 Feb 27;273(9):5174-83
references: 9478971
references: J Biol Chem. 1994 May 6;269(18):13092-9
references: 8175734
references: Blood. 2009 Jan 15;113(3):744-54
references: 19005183
references: Mol Vis. 2007 Aug 27;13:1446-50
references: 17893645
references: Endocrinology. 1995 Nov;136(11):5034-41
references: 7588239
references: Biochem Biophys Res Commun. 1998 Aug 10;249(1):131-7
references: 9705844
references: Arch Biochem Biophys. 2005 Jul 15;439(2):139-53
references: 15967407
references: Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):1977-82
references: 10051580
references: Ophthalmologe. 2011 Jul;108(7):610-4, 616-7
references: 21796509
references: Cell. 1975 May;5(1):19-27
references: 165899
references: J Pharmacol Exp Ther. 2006 Jul;318(1):312-8
references: 16574781